Antidepressants To Strengthen Us Generics Market

As per our new research report, Booming US Generic Drug Market

, the US generics market has witnessed stupendous growth in recent times driven mainly by patent expiration of key blockbuster drugs. As both consumers and the governments are trying to reduce healthcare costs, the country is experiencing a renowned focus on generics by both the entities. In 2009, the US generic drugs sector was valued at US$ 74 Billion, and is likely to grow further at a CAGR of around 10% during 2010-2013. In value terms, generic drugs will contribute a share of around 28% in the US pharmaceutical market by 2013.

The report has identified that the US generics antidepressant market holds a significant growth potential in the years to come. Despite a stable growth rate pattern, the market will seek a boost in future backed by significant investment and product launches. With the patent expiration of Wyeths antidepressant drug Effexor XR, the market is slowly becoming competitive and new generics will further strengthen the participation of the private sector. A long acting version of Prozac patent is expected to expire in 2017, which will again boost growth in the sector.

The report, Booming US Generic Drug Market, evaluates the key drivers spurring the industrys growth and major challenges confronted by the industry. It covers all the important aspects of the US generics market and provides a prudent analysis on the emerging trends, such as injectable generics, anti-counterfeit coalition, and bio-generics among others. Moreover, it also covers a detailed analysis on key therapeutic segments in generics, such as lipid regulator, human insulin, antipsychotics, anti-depressants, etc.

The report is an outcome of an extensive research and prudent analysis on the US generic drugs market that provides reliable statistics and in-depth insight. It effectively evaluates the current and future performance of the market and makes use of proper techniques for forecasting. Moreover, information on key players, their recent activities and SWOT analysis have been included in the report. Overall, the clients will obtain an optimum insight into the US generics market through this analysis covered in this report.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM589.htm

Some of our Related Reports are:

- Generic Drug Market in Canada (http://www.rncos.com/Report/IM598.htm)

- Cancer Generics Market Analysis (http://www.rncos.com/Report/IM353.htm)

- Booming Generics Drug Market in India (http://www.rncos.com/Report/IM256.htm)

- UK Generics Market Analysis (http://www.rncos.com/Report/IM313.htm)

- Japanese Generic Market Forecast to 2013(http://www.rncos.com/Report/IM170.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

by: Shushmul Maheshwari

POST COMMENT

Learn By Heart Today, For It Is The Beginning! Notary Supply Wants Of A Notary Public Notary Supply For Daily Use In A Retirement Planning Guide, Know The Right Age To Say Final Bye To A Job! Cdc Marketfirst On Demand Understanding The Various Aspects Of Ebook Conversion Will Virtual Servers Outlive The Popular Cloud Host Technology? Portable Security Devices Can Make Your Life Easy Shock Absorbers Make The Road A Safer Place The Explanation Behind Pursuing An Executive Mba Course How To Extend The Battery Life Of Your Idevice Four Seasons Of Fabulous Fun Accompany French Courses In Lyon Combining Learning With Pleasure On French Courses In Nice Learning To Parlez En Francais At French School In Nice